Physician profile
John Meek
NPI 1679786230
$12,408.20
in general payments reported to CMS, 2019-2025
15 companies · $4,612 in 2025
The $4,612 reported for 2025 was more than what 91% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $211 · 2020: $59.16 · 2021: $218 · 2022: $2,798 · 2023: $2,450 · 2024: $2,060 · 2025: $4,612.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,650 · Travel and Lodging: $4,472.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,650.42 |
| Travel and Lodging | $4,472.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $5,272.46 | 2022-2025 | Aveir, Thoratec Heartmate 3 Lvas Implant Kit, Tendril |
| Medtronic, INC. | $4,915.08 | 2021-2025 | Linq II, Selectsecure, Micra |
| Boston Scientific Corporation | $791.26 | 2020-2023 | Lux-Dx Insertable Cardiac Monitor |
| Abiomed | $405.35 | 2024-2025 | Impella |
| Novartis Pharmaceuticals Corporation | $189.07 | 2021-2025 | |
| Atricure, INC. | $172.69 | 2022 | |
| Impulse Dynamics (USA) INC. | $163.48 | 2024-2025 | Optimizer |
| Pfizer INC. | $146.20 | 2019 | |
| Heartflow, INC. | $124.64 | 2023 | Ffrct |
| E.R. Squibb & Sons, L.L.C. | $119.21 | 2019-2024 | Camzyos, Eliquis |
| Astrazeneca Pharmaceuticals LP | $26.55 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $25.40 | 2019 | |
| Edwards Lifesciences Corporation | $20.58 | 2022 | |
| Teleflex LLC | $18.66 | 2024 | Manta |
| Amgen INC. | $17.57 | 2025 | Repatha |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Meek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.